• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANDA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANDA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS21
Device Problem Difficult to Fold, Unfold or Collapse (1254)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/16/2018
Event Type  Injury  
Manufacturer Narrative
The devices has not been evaluated by the manufacturer as it was not returned to manufacturer.Reporting event due to possible device malfunction.Further investigation will be carried out on the device as soon as returned to manufacturing facilities.
 
Event Description
An attempt was made to implant a perceval valve.It was reported that the valve would not collapse properly prior to implant.After explanting the valve the physician felt there was a structural issue with the frame.The valve was then replaced with a new perceval valve of same size and it was implanted successfully.
 
Manufacturer Narrative
Preliminary visual inspection confirmed the absence of non-conformities according to valve specifications.A simulation of the collapsing phases was performed using the returned valve and a demonstration accessory kit, in an attempt to replicate the reported event.No problems were encountered during the positioning of the valve.Some difficulty was encountered during the collapsing phase.In particular, some elements of the metallic outflow crown were overlapped.Nevertheless, it was still possible to correctly cover the metallic stent with the dual holder sheath.The inflow portion was correctly captured by the holder.Based on the event description, it is not possible to confirm whether the identified overlapping is related to the difficulty encountered with the collapsing procedure.It was stated that the valve could not be collapsed; however, the investigation performed did not specifically reproduce this report.Nevertheless, it should be noted that a specific warning on the overlapping phenomena is included in the perceval ifu: "warning: check that the struts are evenly collapsed and their elements are not overlapped." the manufacturing and material records for the perceval heart valve, model #icv1208 , s/n # (b)(4), and nitinol stent, as they pertain to the reported event, were retrieved and reviewed by quality engineering at (b)(4).The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1208) perceval heart valve at the time of manufacture and release.Based on the investigations performed, the collapsing difficulty may be attributable to the overlapping phenomenon identified, although this cannot be confirmed.Given that the ifu of the device warns that the stent should be inspected for overlapping, the event can reasonably be deemed a failure to follow instructions.Additional information was received clarifying that the valve was not explanted.The collapsing issue occurred prior to implant.The event description was updated to reflect the information received.
 
Event Description
An attempt was made to implant a perceval valve.It was reported that the valve would not collapse properly prior to implant.The valve was then replaced with a new perceval valve of same size and it was implanted successfully.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANDA CORP
5005 north fraser way
burnaby, british columbia V5J5M 1
CA  V5J5M1
MDR Report Key7887672
MDR Text Key120708488
Report Number3004478276-2018-00292
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000412
UDI-Public(01)00896208000412(240)ICV1208(17)201111
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup
Report Date 10/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/18/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/11/2020
Device Model NumberPVS21
Device Catalogue NumberICV1208
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/25/2018
Was the Report Sent to FDA? No
Date Manufacturer Received09/25/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age57 YR
-
-